The most popular stories of 2025 by Adam Sheldon December 17, 2025December 18, 2025 For Australia’s medicinal cannabis industry, 2025 was – in line with recent years – a complex […]
Montu revenues exceed $385m but profits slide amid rising competition by Steve Jones December 10, 2025December 11, 2025
Montu and TGA set for seven-day trial as mediation deadline looms by Steve Jones December 10, 2025December 10, 2025
News in brief: Avecho gains key patent allowances; Montu expands medical affairs team by Adam Sheldon December 9, 2025February 21, 2026
Montu-commissioned survey finds strong public support for medicinal cannabis and telehealth by Adam Sheldon November 18, 2025February 21, 2026
Montu names Myles Lawlor as first Australian chief executive by Adam Sheldon November 12, 2025February 21, 2026
Montu, Penington become latest to reject call to curb category 5 medicine by Adam Sheldon October 23, 2025October 23, 2025
Montu calls for single prescriber framework in TGA submission by Adam Sheldon August 28, 2025August 28, 2025
Fresh criticism of prescribing volumes illustrate ‘urgency’ of industry unity by Steve Jones July 31, 2025August 4, 2025
